by Wade Emmert

Wade’s Health Law Highlights for November 17, 2026

Fraud & Abuse / Exclusion Screening

  • OIG approved a drug manufacturer’s plan to pay for autoantibody testing that helps determine whether its drug for a rare lung disease may be appropriate for a patient. Under Advisory Opinion 26-20, the manufacturer would pay a third-party laboratory a fixed fee per test, and the test would be free to any patient with an abnormal CT scan, a qualifying symptom, and a health care professional’s attestation, regardless of income or insurance status. No patient or payor would be billed, the test is not reimbursable by Federal health care programs, and the manufacturer expects most results to be negative. OIG found the free test implicates the Federal anti-kickback statute and that no safe harbor applies, but it will not impose sanctions because sales representatives cannot promote the program, the manufacturer receives only aggregated, de-identified data, and ordering professionals are not paid or required to prescribe the drug. OIG also concluded the arrangement satisfies the Promotes Access to Care Exception to the Beneficiary Inducements CMP. The opinion will have no effect if FDA does not approve the drug. Source: OIG
  • Federal regulations do not require hospitals to screen the Medicare Preclusion List, but a hospital can take on that obligation through its Medicare Advantage contracts or delegated arrangements. The Preclusion List payment restrictions apply to Medicare Advantage organizations and Part D sponsors, which may not pay for items, services, or drugs furnished, ordered, or prescribed by listed providers, and CMS makes the list available only to plans. An OIG-excluded provider goes on the Preclusion List as of the exclusion date, but a provider may be precluded without being excluded, so a clear LEIE search does not establish that a Medicare Advantage claim is payable. Since October 14, 2026, the CMS Administrator can exercise the Secretary’s permissive exclusion authority under section 1128(b) of the Social Security Act, so hospitals relying on the LEIE should confirm whether their screening vendor will capture CMS-imposed exclusions. Hospitals that discover an excluded individual face the 60-day overpayment rule and civil monetary penalty exposure, and OIG’s updated Self-Disclosure Protocol and a DOJ, OIG, and CMS False Claims Act self-disclosure pilot running through April 22, 2027 offer resolution paths. Source: Holland & Hart Health Law Blog

HIPAA & Data Privacy

GLP-1 Drugs

Artificial Intelligence

Texas Legislature

  • Two bills filed to expand Medicaid eligibility on November 9, the first day of pre-filing for the 90th Texas Legislature. House Bill 101 would put Medicaid expansion to a statewide vote for all applicants for whom federal funds are available, and House Bill 102 would direct the executive commissioner of the Texas Health and Human Services Commission to “take all necessary actions” to expand the program administratively. Bucy has filed the same legislation in prior sessions and has also tried to expand Medicaid through budget amendments. Rep. Senfronia Thompson, who named health care as one of her priorities, said she has the votes to become the next House speaker. The Legislature convenes on January 12. Source: The Texan

Practice Operations

Wade Emmert Avatar

Written by

More Issues